Hims Lawsuit 2026: Claims, Settlements & Who Qualifies

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

Latest Update (as of September 19, 2026): The most significant development since this article was first published is that on July 29, 2026, the FTC — joined by the states of California (through Los Angeles County Counsel) and Utah — filed a formal lawsuit against Hims & Hers in the U.S. District Court for the Northern District of California. The complaint alleges the company shared consumers’ sensitive health information with third-party advertising platforms, including Meta and Snap, despite promising to protect patient privacy, and that it used deceptive billing, subscription, and cancellation practices. Hims & Hers has denied wrongdoing and called the suit an attempt to generate headlines. Separately, a securities class action covering investors who bought Hims stock between August 4, 2025 and July 29, 2026 is moving forward, with a lead plaintiff deadline of November 2, 2026.

Last updated: September 2026

Hims & Hers Health is facing multiple lawsuits in 2026, and if you’ve ever paid for their subscriptions, weight loss drugs, or hair loss products, you may have a claim worth pursuing. The hims lawsuit covers everything from false advertising and deceptive billing to the murky world of compounded semaglutide and telehealth marketing that regulators say crossed legal lines.

Readers also liked: James Henry Lawsuit 2026: Full Settlement and Claim Guide

This isn’t just one case. It’s a collection of overlapping legal actions targeting one of the fastest-growing direct-to-consumer health companies in the United States.

In this article, you’ll find out exactly what each lawsuit is about, which products are involved, who qualifies for compensation, and how to file a claim before any deadline passes.

One key number to keep in mind: some consumer fraud class actions in this industry have resulted in settlements worth tens of millions of dollars. The Hims cases could land in the same range.

What Is the Hims Lawsuit?

The Hims lawsuit refers to a group of legal actions filed against Hims & Hers Health, Inc. for allegedly deceiving customers through false advertising, subscription billing traps, and misleading claims about prescription health products.

These aren’t minor complaints. Plaintiffs allege the company violated federal consumer protection laws and multiple state statutes, including California’s Unfair Competition Law and the Consumers Legal Remedies Act.

The core issue: customers say Hims promised results, charged recurring fees without proper consent, and sold products that didn’t live up to their marketing claims.

The company has publicly denied many of these allegations. Courts are still sorting out which cases move forward as certified class actions and which get dismissed or settled individually.

What Is the Hims & Hers Lawsuit About?

The Hims & Hers lawsuit is about the company’s business practices across multiple product lines, not just one specific incident or drug.

Think of it like a department store where every department has a problem. The hair section is selling products with unproven results. The weight loss aisle is pushing compounded drugs under questionable FDA guidance. The checkout is charging customers who never agreed to recurring fees.

That’s the big picture here.

The company operates across several categories:

• Erectile dysfunction treatments
• Hair loss products and topicals
• Weight loss medications including GLP-1 drugs
• Mental health prescriptions
• Skincare and general wellness

Plaintiffs in the Hims & Hers lawsuit say the company used aggressive digital marketing, manipulated before-and-after imagery, and buried subscription terms in fine print that most customers never read.

Separately, securities fraud lawsuits claim the company misled investors about its financial position and the legality of its compounding pharmacy business. That’s a different set of plaintiffs, but the same defendant.

Is Hims Being Sued Right Now?

Yes, Hims & Hers Health is actively being sued in 2026 across multiple federal and state courts.

The company is not facing a single unified lawsuit. It’s dealing with a cluster of legal actions filed at different times, by different plaintiff groups, covering different claims.

Here’s the current situation as of 2026:

• Consumer class actions targeting billing and false advertising remain in pre-trial or settlement negotiation phases
• Securities class actions involving stock price manipulation and misleading investor statements are at various stages in federal court
• Regulatory pressure from the FDA related to compounded semaglutide continues to shape potential future claims
• Individual state AG investigations have been reported in California and New York

The company has not folded under this pressure. Hims & Hers continues to operate and expand. But the legal exposure is real, and the cases are moving forward.

Key Takeaway: As of 2026, Hims & Hers Health faces multiple active lawsuits involving consumer fraud, securities violations, and regulatory non-compliance across several product lines.

Hims Lawsuit Update 2026: What Has Changed?

The biggest development in the Hims lawsuit for 2026 is the fallout from the FDA’s position on compounded semaglutide shortages.

In 2024 and 2025, the FDA declared that the semaglutide shortage had ended. That meant compounding pharmacies, including those supplying products sold through platforms like Hims, were no longer legally permitted to produce semaglutide at scale. Hims continued selling compounded versions. That decision became central to new legal filings in 2025 and 2026.

At the same time, the FTC began reviewing subscription cancellation practices in the telehealth industry broadly. Hims was named specifically in consumer complaint data reviewed by federal investigators.

If you filed a claim or registered interest before 2026, check your email. Settlement administrators may be reaching out with eligibility confirmation or payout instructions.

Hims False Advertising Lawsuit: What Were the Claims?

The Hims false advertising lawsuit centers on the company’s use of misleading marketing to sell health products that, according to plaintiffs, didn’t perform as advertised.

The most visible issue: before-and-after photos on the Hims website and app that allegedly showed results that were not typical, not disclosed as atypical, and sometimes not even connected to the product being sold.

Federal advertising law, specifically FTC guidelines, requires that testimonials and results be representative of what a typical customer can expect. Plaintiffs say Hims ignored those rules.

Specific false advertising claims include:

• Hair regrowth products marketed as clinically proven when underlying studies were selectively cited
• Weight loss outcomes linked to lifestyle changes, not just the drug being sold
• ED treatment success rates quoted without disclosing study limitations
• Mental health medication benefits overstated in promotional copy

California’s CLRA and UCL give consumers the right to sue for these violations without needing to prove individual harm. That’s what makes this a strong class action candidate.

Bold fact: The FTC has settled similar cases against direct-to-consumer health companies for amounts ranging from $5 million to $193 million in recent years.

Hims Subscription Lawsuit: What Did Customers Allege?

The Hims subscription lawsuit alleges that the company enrolled customers in recurring billing plans without clear, informed consent and then made it difficult to cancel those subscriptions.

This is one of the most relatable complaints in the entire Hims legal saga. If you’ve ever signed up for what you thought was a one-time purchase and then seen a charge hit your card every month, you understand the frustration.

Customers reported several specific problems:

• Subscription terms were buried in checkout flow fine print
• Cancellation required navigating multiple steps through the app
• Some customers reported being charged after attempting to cancel
• Refund requests were denied despite cancellation confirmations

California’s Automatic Renewal Law requires companies to present subscription terms clearly, get affirmative consent, and provide a simple cancellation mechanism. Plaintiffs allege Hims failed all three requirements.

Estimated class size: Hundreds of thousands of Hims subscribers could be affected by these subscription-related claims based on the company’s reported customer numbers.

Hims Billing Lawsuit: Were Customers Charged Without Consent?

The Hims billing lawsuit goes one step beyond the subscription dispute. It alleges that in some cases, Hims charged customers who never agreed to recurring billing at all.

This is an unauthorized charge claim. That’s a more serious legal allegation than a confusing cancellation process. It potentially triggers violation of the Electronic Funds Transfer Act, state consumer protection statutes, and banking regulations.

Customers who filed complaints reported:

• Charges appearing after a free trial with no clear notice that paid billing would begin
• Double charges appearing on credit card statements for the same period
• Charges continuing for months after cancellation was confirmed via email
• No way to reach a billing representative without long wait times

These billing claims are often what push a class action from a nuisance lawsuit to a settlement-forcing action. Companies don’t want detailed billing records examined in discovery.

Key Takeaway: The billing and subscription lawsuits against Hims are among the most legally solid parts of the case because they involve specific, documented financial transactions that are easy to verify.

Hims Semaglutide Lawsuit: What Is the Weight Loss Drug Case About?

The Hims semaglutide lawsuit targets the company’s sale of compounded semaglutide as a weight loss treatment during a period when regulatory guardrails were being actively debated and then changed.

Semaglutide is the active ingredient in Ozempic and Wegovy. Hims sold a compounded version through its platform, marketed aggressively to people looking for affordable access to GLP-1 weight loss drugs.

The legal problem: compounded drugs are only permitted when an FDA-approved version is unavailable due to a shortage. Once the FDA determined the shortage was over, continued sales of compounded semaglutide became legally questionable.

Plaintiffs claim Hims:

• Continued selling compounded semaglutide after FDA guidance changed
• Did not clearly disclose to customers that the product was compounded and not FDA-approved
• Charged premium prices for a product of uncertain safety and efficacy
• Failed to fully disclose the regulatory status of the medication in its marketing

The semaglutide angle is the most significant piece of the Hims lawsuit in 2026. It’s what attracted the most media attention and what pushed new plaintiffs to file claims in late 2025 and early 2026.

Hims Compounding Pharmacy Lawsuit: Why Did the FDA Get Involved?

The Hims compounding pharmacy lawsuit exists because federal law draws a sharp line between FDA-approved drugs and compounded versions, and the company reportedly walked up to that line and crossed it.

The FDA regulates compounding pharmacies under the Federal Food, Drug, and Cosmetic Act. Compounded drugs don’t go through the same approval process as brand-name medications. They’re only legal at scale when an FDA-approved equivalent is unavailable.

Here’s the timeline that created the legal exposure:

The FDA sent warning letters to compounding pharmacies and telehealth platforms in this space. Whether Hims received a direct warning letter is part of what litigation discovery may reveal.

Plaintiffs claim this makes every sale of compounded semaglutide after the shortage ended a potentially fraudulent transaction.

A closely related topic: Live Olympics Lawsuit 2026: Settlement and Filing Update

Hims GLP-1 Lawsuit: What Do Plaintiffs Claim?

The Hims GLP-1 lawsuit is related to the semaglutide case but focuses specifically on how GLP-1 receptor agonist drugs were marketed and sold to consumers.

GLP-1 drugs work by mimicking a hormone that regulates appetite and blood sugar. They’ve become enormously popular for weight loss. Hims capitalized on that demand aggressively.

Plaintiffs in the GLP-1 case claim:

• Hims marketed GLP-1 medications without adequately disclosing side effects
• The company implied the compounded versions were equivalent to brand-name Ozempic or Wegovy
• Customers paid hundreds of dollars per month for products that may not have been legal to sell
• Some customers experienced adverse effects and allege they weren’t given full safety information

A secondary claim involves pricing. Hims advertised GLP-1 medications as “affordable” alternatives. Plaintiffs argue the pricing was only affordable because the company was selling a compounded product that bypassed the cost of full FDA approval, without making that trade-off clear.

Key Takeaway: The GLP-1, semaglutide, and compounding pharmacy lawsuits are deeply connected and together represent the most legally complex and financially significant part of the Hims litigation in 2026.

Hims Hair Loss Lawsuit: What Products Are Under Scrutiny?

The Hims hair loss lawsuit targets the company’s finasteride and minoxidil-based products, along with topical hair serums and subscription kits marketed with promises that plaintiffs say were not backed by honest evidence.

Hair loss treatment is actually where Hims started. It was the company’s original flagship product. And it’s also where some of the earliest consumer complaints originated.

Products named in various complaints include:

• Oral finasteride subscriptions
• Topical minoxidil solutions
• “Complete Hair Kit” subscription bundles
• Volumizing shampoo and conditioner sold as part of hair regrowth systems

The specific legal claims:

• Marketing materials implied clinical-grade hair regrowth when results varied significantly by individual
• Before-and-after photos did not represent typical outcomes
• Subscription bundles auto-renewed without clear notice
• Product formulations changed without notifying existing subscribers

Finasteride is an FDA-approved drug, so the core product isn’t illegal. But the way it was marketed and bundled into subscription kits is what’s under legal scrutiny.

Hims Telehealth Lawsuit: Were Patients Misled About Medical Care?

The Hims telehealth lawsuit addresses whether the company’s online prescription platform gave customers a genuine medical consultation or a rubber-stamp process designed to maximize prescription volume.

This is a serious allegation. Telehealth platforms are supposed to connect patients with licensed providers who make independent medical judgments. Plaintiffs claim Hims ran a system where prescriptions were issued with minimal clinical review.

Specific telehealth-related claims include:

• Online questionnaires used as a substitute for real clinical evaluation
• Prescriptions issued within minutes of questionnaire completion
• No follow-up care or monitoring for ongoing prescriptions
• Patients prescribed medications that later interacted badly with other drugs they disclosed in their intake form
• Providers allegedly working on volume-based incentives, not clinical outcomes

The telehealth claims are harder to certify as a class because they involve individual medical decisions. But they may be viable as individual claims or in consolidated litigation.

Hims FDA Lawsuit: What Role Did Federal Regulators Play?

The Hims FDA lawsuit isn’t a case where the FDA sued Hims directly. It refers to the legal cases that were triggered or strengthened by FDA enforcement actions and guidance changes.

The FDA’s role here is as a backdrop, not a plaintiff. When the agency changes rules or issues warnings, those actions become evidence in civil litigation.

Here’s how FDA actions fed into the lawsuits:

• The FDA’s declaration that the semaglutide shortage had ended gave plaintiffs the legal footing to argue continued sales were unlawful
• FDA warning letters to compounding pharmacies in general created a record showing the industry knew the rules had changed
• FDA guidance on telehealth prescribing standards gave plaintiffs a benchmark to measure Hims against
• Novo Nordisk, maker of Ozempic, also filed legal action against compounding pharmacies, which added credibility to arguments about the illegality of scaled compounding

Think of the FDA’s role the way you’d think of a traffic camera. The FDA didn’t cause the accident. But the footage it captured is now being used in court.

Key Takeaway: FDA regulatory actions in 2024 and 2025 directly strengthened the legal foundation for consumer claims against Hims in 2026, particularly in the semaglutide and compounding pharmacy cases.

Who Qualifies for the Hims Lawsuit?

You may qualify for the Hims lawsuit if you purchased products or subscriptions from Hims & Hers Health and were harmed by deceptive practices, unauthorized charges, or misleading medical claims.

The qualification criteria vary depending on which specific lawsuit you’re joining. Here’s a general breakdown:

You don’t need to have suffered a physical injury to qualify for most consumer protection claims. Financial harm, meaning you paid for something that wasn’t what it was advertised to be, is generally enough.

Keep records of your purchases, subscription confirmations, and any communications with Hims customer service. Those will support your claim.

What Is the Hims Class Action Lawsuit?

A class action lawsuit is a legal case where one or more individuals sue on behalf of a large group of people who experienced the same harm.

The Hims class action lawsuit groups together thousands of customers who share similar complaints against the company. Instead of each person filing separately, they’re combined into one case that’s more efficient to litigate and harder for a defendant to ignore.

Why class actions matter for consumers:

• They allow people with smaller individual losses to seek compensation together
• They create leverage against large corporations that might otherwise fight individual claims
• They can result in settlements that cover all class members, even those who didn’t actively participate

To become a certified class action, a court must find that:

• There are enough affected people (typically thousands)
• The legal questions are common across the group
• The named plaintiff can adequately represent the class

The Hims cases appear to meet those thresholds based on the company’s reported subscriber base of over one million customers.

Hims Settlement Amount: How Much Could You Get?

The Hims settlement amount will depend on which case settles, how large the settlement fund is, and what tier your claim falls into.

No final settlement has been publicly announced for the major Hims consumer class actions as of early 2026. Negotiations are ongoing. But based on comparable cases, we can estimate realistic ranges.

These are estimates based on settlement structures in similar telehealth and direct-to-consumer pharmaceutical class actions. The actual amounts will depend on the total settlement fund and the number of valid claims filed.

Securities class members, meaning investors who lost money on Hims stock, operate under a completely different calculation tied to share price loss.

If you’re curious, also see Johns Hopkins Lawsuit: Full Settlement Guide 2026

Hims & Hers Class Action Settlement Payout: How Is It Calculated?

The Hims & Hers class action settlement payout is calculated using a formula that weighs how much you spent, what harm you experienced, and how many valid claims are submitted in total.

This is how most class action settlements work. There’s a fixed pot of money. The more valid claims filed, the smaller each individual share. The more documented harm, the higher your individual tier.

Factors that increase your payout:

You may want to read Major Pandemic Lawsuit 2026: Settlement and Filing Guide

• Larger total spending with Hims
• Documented adverse health effects
• Receipts or bank statements proving unauthorized charges
• Written communications with Hims showing you attempted to cancel
• Purchase of specifically named products like compounded semaglutide

Factors that reduce your payout:

• No documentation of purchase
• Claim filed after the deadline
• Opting out of the class and not filing individually
• Previously accepted a refund from Hims directly

Settlement payments in comparable cases have typically been distributed 9 to 18 months after a settlement is formally approved by the court. Given the 2025 to 2026 filing timeline, payments could begin in late 2026 or early 2027 if cases settle soon.

Key Takeaway: Your payout in any Hims settlement will be significantly higher if you have documentation. Save every receipt, email, and bank statement related to your Hims purchases right now.

How to File a Claim in the Hims Lawsuit

Filing a claim in the Hims lawsuit requires you to monitor for an official settlement notice and submit your claim through the designated settlement administrator’s portal before the deadline.

Here’s the step-by-step process:

Step 1: Confirm You Qualify
Review the eligibility criteria for the specific Hims case you want to join. Different cases cover different products and time periods.

Step 2: Gather Your Documentation
Collect:

• Purchase receipts or order confirmations from Hims
• Bank or credit card statements showing charges
• Emails from Hims, especially cancellation confirmations
• Any medical records related to Hims products if you experienced harm
• Screenshots of marketing claims you relied on

Step 3: Register Your Interest
Some class action cases allow pre-registration before a formal settlement. Search for the specific case name on legal aggregator sites and register your contact information so you receive official notice when the settlement opens.

Step 4: Submit Your Claim Form
Once a settlement is approved, a claim form will be made available. Fill it out completely. Submit all supporting documentation. Keep a copy of everything.

Step 5: Wait for Court Approval
After the claims period closes, the court reviews the settlement and issues final approval. Payments follow after that process is complete.

Don’t wait for the lawsuit to fully settle before gathering your documents. The time to prepare is now, while records are still accessible.

Frequently Asked Questions

What is the Hims lawsuit about in 2026?

The Hims lawsuit in 2026 covers multiple legal actions targeting the company for false advertising, deceptive subscription billing, and the sale of compounded semaglutide weight loss drugs.

The cases involve consumer protection claims, securities fraud allegations, and regulatory violations connected to FDA guidance changes.

Claims span multiple product categories including hair loss treatments, GLP-1 medications, erectile dysfunction products, and telehealth prescription services.

How much money can I get from the Hims settlement?

Most consumer claimants could receive between $10 and $500 depending on their specific claim type and documentation.

Customers with documented medical harm or larger financial losses may qualify for higher tiers reaching several thousand dollars.

No final settlement amount has been officially announced as of early 2026.

Who qualifies for the Hims class action lawsuit?

Anyone who purchased Hims & Hers Health products or subscriptions and experienced unauthorized charges, misleading marketing, or harm from compounded semaglutide may qualify.

The qualifying purchase period generally runs from 2019 through 2025, depending on the specific case.

Investors who bought Hims stock during certain periods may qualify separately under the securities fraud class action.

Has Hims & Hers settled any lawsuits yet?

Hims & Hers has faced and partially resolved some earlier legal disputes, but the major consumer class actions related to semaglutide and billing are not fully settled as of 2026.

Settlement negotiations are reportedly ongoing in several cases.

Any final settlement would require court approval before payments are distributed.

How do I file a claim in the Hims lawsuit?

You file a claim by registering your interest now, gathering purchase and billing documentation, and submitting an official claim form once a settlement is formally announced.

The claim form will be available through a court-appointed settlement administrator.

Acting early and keeping thorough records gives you the best chance of receiving the maximum payout you’re eligible for.

The Hims lawsuit situation in 2026 is real, it’s active, and it affects a very large number of people who used the platform in good faith. If you bought hair loss products, weight loss drugs, or any Hims subscription and felt the results, billing, or medical information didn’t match what you were promised, you likely have standing to pursue compensation.

Start by pulling together your purchase history and any communications with the company. Documentation is everything in a class action.

Stay alert for official settlement notices. When the claims period opens, file promptly. Deadlines in class action cases are firm, and missing one means losing your right to compensation entirely.

A closely related topic: South Park Lawsuit vs Paramount: Full 2026 Update

A closely related topic: Vital Farms Lawsuit 2026: Eggs, Claims, and Your Rights

A related guide: Education Lawsuit Last Week: 2026 Payout and Filing Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.